Impact of pharmaceutical underutilization: A study of insurance drug claims data

Journal of the American Pharmaceutical Association

Volumn 37, Issue 5, 1997, Pages 511-516

  Harrow, B S ^a   Strom, B L ^a   Gans, J A ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DIGOXIN; DILTIAZEM; GLIBENCLAMIDE; HALOPERIDOL; HYDROCHLOROTHIAZIDE; LEVOTHYROXINE; METHYLDOPA; MEVINOLIN; PHENYTOIN; PREDNISONE; PROBUCOL; QUINIDINE; THEOPHYLLINE;

ADULT; AGE; AGED; ARTICLE; DRUG DOSE; DRUG USE; HUMAN; INSURANCE; PATIENT COMPLIANCE; TREATMENT OUTCOME; CHRONIC DISEASE; COMPARATIVE STUDY; FEMALE; HEALTH INSURANCE; MALE; METHODOLOGY; MIDDLE AGED; TREATMENT REFUSAL; UNITED STATES;

AGED; CHRONIC DISEASE; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; TREATMENT REFUSAL; UNITED STATES;

EID: 0031450691     PISSN: 10865802     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1086-5802(16)30254-6     Document Type: Article

References (19)

1. M.C. Smith The cost of non-compliance. In: Improving Medication Compliance: Proceedings of a Symposium 1984 National Pharmaceutical Council Washington DC 7
2. M. Cowen L.K. Jim E.L. Boyd Some possible effects of patient non· compliance JAM A. 245 1981 1121
3. S.E. Frankl J.L. Breeling L. Goldman Preventability of emergent hospital readmission Am J Med. 90 1991 667 674
4. I. Clepper Noncompliance: the invisible epidemic Drug Topics. 1992 44 August 17:
5. J.A. Johnson J.L. Bootman Drug-related morbidity and mortality. A cost-of-illness model Arch Intern Med 1558 1995 1949 1956
6. A. Spagoli G. Ostino A.D. Barga Drug compliance and unreported drugs in the elderly JAm Geriatr Soc. 37 1989 619
7. N. Col J.E. Fanale P. Kronholm The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly Arch Intern Med. 150 1990 841 845
8. R. Chadwick M. Levitt When drug treatment in the elderly is not cost effective. An ethical dilemma in an environment of health care Drugs Aging 7 1995 416 419
9. J. Williamson Introduction M.J. Denham C.F. George Drugs in Old Age: New Perspectives. Bri Med Bull 46 1990 5
10. Office of the Inspector General. Medication Regimens: Causes of Non·compliance. Office of Evaluation and Inspections. March 1990.
11. R.F. Maronde L.S. Chan F.J. Larsen Underutilization of antihypertensive drugs and associated hospitalization Med Care. 27 1989 1159
12. H. Pickles Prescriptions, adverse reactions, and the elderly Lancet. 2 1986 40
13. H.L. Lipton P.R. Lee Drugs and the Elderly: Clinical, Social and Policy Perspectives 1988 Stanford University Press Stanford, Calif
14. H. Graham B. Livesley Can readmissions to a geriatric medical unit be prevented? Lancet. 1 1983 404
15. T.J. McKenney W.L. Harrison Drug-related hospital admissions Am J Hosp Pharm. 8 1976 33
16. Smith DL. “The high cost of not complying with prescription drugs. Business and”. Health. 1987; April:30.
17. T.R. Einarson Drug-related hospital admissions Ann Pharmacother. 27 1993 832 840
18. S. Frankel Methodological observations on applied behavioral science· J Applied Behav Sci. 23 1987 543
19. J. Melnikow C. Kiefe Patient compliance and medical research: issues in methodology J Gen Intern Med. 9 1994 96 105